| [1] |
.
[J]. Clinical Focus, 2024, 39(2): 177-182.
|
| [2] |
.
[J]. Clinical Focus, 2024, 39(1): 84-87.
|
| [3] |
Yang Zhibin, Shao Yanfang, Pan Li, Yang Yanxia, Yang Yuxi, Zhao Lihui, Zeng Rongkun, Li Yang, Wang Qiaofeng, Wang Cong, Ma Shiwu.
Efficacy of magnesium isoglycyrrhizinate in anti-tuberculosis drug-induced liver injury
[J]. Clinical Focus, 2021, 36(11): 972-975.
|
| [4] |
.
[J]. Clinical Focus, 2021, 36(9): 856-860.
|
| [5] |
.
[J]. Clinical Focus, 2021, 36(6): 574-576.
|
| [6] |
.
[J]. CLINICAL FOCUS, 2014, 29(2): 202-203.
|
| [7] |
.
[J]. CLINICAL FOCUS, 2013, 28(7): 812-813.
|
| [8] |
WANG Pu;LIU Jiang-wen;TONG De-feng;CUI Yong.
Effects of 15-deoxy-prostaglandin J2 on expression of proliferator-activated receptor γ,tumor necrosis factor-α and interleukin-6 in liver tissue of rats with nonalcoholic fatty liver disease
[J]. Clinical Focus, 2013, 28(4): 412-0.
|
| [9] |
.
[J]. Clinical Focus, 2012, 27(22): 1993-1994.
|
| [10] |
.
[J]. Clinical Focus, 2012, 27(18): 1610-1611.
|
| [11] |
ZHANG Jun-xia;LIU Jun-juan;LI Jia.
Clinical characteristics of 42 autoimmune hepatitis patients
[J]. Clinical Focus, 2012, 27(12): 1050-1053.
|
| [12] |
.
[J]. Clinical Focus, 2011, 26(24): 2170-2171.
|
| [13] |
.
[J]. CLINICAL FOCUS, 2011, 26(20): 1811-1813.
|
| [14] |
.
[J]. CLINICAL FOCUS, 2010, 25(24): 2174-2174.
|
| [15] |
.
[J]. CLINICAL FOCUS, 2010, 25(23): 2106-2108.
|
